Examples of Medical CBRN Defense Consortium in a sentence
The U.S. Army Contracting Command-New Jersey (ACC-NJ) is entering into a Section 815 Prototype Other Transaction Agreement (OTA) with the Medical CBRN Defense Consortium, c/o Advanced Technology International 000 Xxxxx Xxxxx, Xxxxxxxxxxx, XX 00000.
Section 3.01 The Medical CBRN Defense Consortium (MCDC) The MCDC, as defined in the OTA, was formed to work with the Government and provide input in developing technologies to support the Department of Defense’s (DoD) medical, pharmaceutical, and diagnostic requirements as related to enhancing the mission effectiveness of military personnel ultimately resulting in fully executed research and development prototype projects selected by the Government.
Following the lead of green chemistry and the priorities of H2020, the use of C-dots would allow reducing the use of poisoning heavy metals, (Cd, Sb, Pb, etc.) or rare earths elements (La, Er, Ga, etc.), largely applied for photonics solutions.
Individual in-depth interviews were distributed among the villages (see Appendix C for distribution of focus group discussions and in-depth interviews).
NuIS has extensive experiences in partnering with its various Government and non-government clients by blending its staff with client’s Information Systems organization.
Bill Gates and the Pentagon will make huge profits with funding.The initial development of CELLECTRA 3PSP began in 2019 with a grant of $ 8.1 million from the medical branch of the Medical CBRN Defense Consortium U.S. Defense Threat Reduction Agency (DTRA).The coronavirus was created in 2015 in the US National Laboratory + Galveston at the University of Texas.
Signed, dated, unredacted July 20, 2020 Medical CBRN Defense Consortium (MCDC) Base Agreement No. 2020-532,122 signed between Advanced Technology International (ATI) and Pfizer, Inc.
The Medical CBRN Defense Consortium (MCDC)12 currently includes 318 large and small businesses and academic entities that “support the Department of Defense’s (DoD) medical pharmaceutical and diagnostic requirements to counter Chemical, Biological, Radiological and Nuclear (CBRN) threat agents” and enable “prototype technologies for therapeutic medical countermeasures targeting viral, bacterial and biological toxin targets of interest to the DoD,” including the development of vaccines.
The $450 million Regeneron contract is listed as an awarded agreement at the Medical CBRN Defense Consortium (MCDC) website.
This effort improved the DoD and interagency acquisition efforts to improve delivery of CBRN detection, protection, and prevention capabilities and built on the established Medical CBRN Defense Consortium.